Elizabeth M Keiley - Net Worth and Insider Trading
Elizabeth M Keiley Net Worth
The estimated net worth of Elizabeth M Keiley is at least $693,415 dollars as of 2024-11-05. Elizabeth M Keiley is the SVP & General Counsel of Oxford Immunotec Global PLC and owns about 26,928 shares of Oxford Immunotec Global PLC (OXFD) stock worth over $592,147. Elizabeth M Keiley is also the General Counsel of Entasis Therapeutics Holdings Inc and owns about 46,241 shares of Entasis Therapeutics Holdings Inc (ETTX) stock worth over $101,268. Details can be seen in Elizabeth M Keiley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elizabeth M Keiley has not made any transactions after 2021-10-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Elizabeth M Keiley
Elizabeth M Keiley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elizabeth M Keiley owns 2 companies in total, including Entasis Therapeutics Holdings Inc (ETTX) , and Oxford Immunotec Global PLC (OXFD) .
Click here to see the complete history of Elizabeth M Keiley’s form 4 insider trades.
Insider Ownership Summary of Elizabeth M Keiley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc | 2021-10-19 | General Counsel |
| OXFD | Oxford Immunotec Global PLC | 2019-03-04 | SVP & General Counsel |
Elizabeth M Keiley Latest Holdings Summary
Elizabeth M Keiley currently owns a total of 2 stocks. Among these stocks, Elizabeth M Keiley owns 26,928 shares of Oxford Immunotec Global PLC (OXFD) as of March 4, 2019, with a value of $592,147 and a weighting of 85.4%. Elizabeth M Keiley also owns 46,241 shares of Entasis Therapeutics Holdings Inc (ETTX) as of October 19, 2021, with a value of $101,268 and a weighting of 14.6%.
Latest Holdings of Elizabeth M Keiley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OXFD | Oxford Immunotec Global PLC | 2019-03-04 | 26,928 | 21.99 | 592,147 |
| ETTX | Entasis Therapeutics Holdings Inc | 2021-10-19 | 46,241 | 2.19 | 101,268 |
Holding Weightings of Elizabeth M Keiley
Elizabeth M Keiley Form 4 Trading Tracker
According to the SEC Form 4 filings, Elizabeth M Keiley has made a total of 0 transactions in Oxford Immunotec Global PLC (OXFD) over the past 5 years. The most-recent trade in Oxford Immunotec Global PLC is the sale of 4,100 shares on March 4, 2019, which brought Elizabeth M Keiley around $69,700.
According to the SEC Form 4 filings, Elizabeth M Keiley has made a total of 1 transactions in Entasis Therapeutics Holdings Inc (ETTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Entasis Therapeutics Holdings Inc is the sale of 3,759 shares on October 19, 2021, which brought Elizabeth M Keiley around $11,991.
Insider Trading History of Elizabeth M Keiley
- 1
Elizabeth M Keiley Trading Performance
Elizabeth M Keiley Ownership Network
Ownership Network List of Elizabeth M Keiley
Ownership Network Relation of Elizabeth M Keiley
Elizabeth M Keiley Owned Company Details
What does Entasis Therapeutics Holdings Inc do?
Who are the key executives at Entasis Therapeutics Holdings Inc?
Elizabeth M Keiley is the General Counsel of Entasis Therapeutics Holdings Inc. Other key executives at Entasis Therapeutics Holdings Inc include 10 percent owner Theravance Inc , VP & Principal Fin & Acct Off Kristie Ann Wagner , and Chief Medical Officer David Altarac .
Entasis Therapeutics Holdings Inc (ETTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entasis Therapeutics Holdings Inc Insider Transactions
Elizabeth M Keiley Mailing Address
Above is the net worth, insider trading, and ownership report for Elizabeth M Keiley. You might contact Elizabeth M Keiley via mailing address: C/o Entasis Therapeutics Holdings Inc. 35 Gatehouse Drive Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
